trimethoprim has been researched along with Episcleritis in 2 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, M | 1 |
| Patnaik, G | 1 |
| Sanghvi, K | 1 |
| Anand, AR | 1 |
| Janani, MK | 1 |
| Biswas, J | 1 |
| Kattan, HM | 1 |
| Pflugfelder, SC | 1 |
2 other studies available for trimethoprim and Episcleritis
| Article | Year |
|---|---|
Clinicopathological, Microbiological and Polymerase Chain Reaction Study in a Case of Nocardia Scleritis.
Topics: Administration, Oral; Adult; Amikacin; Anti-Bacterial Agents; Cefuroxime; DNA, Bacterial; Drug Combi | 2021 |
Nocardia scleritis.
Topics: Female; Humans; Middle Aged; Necrosis; Nocardia Infections; Sclera; Scleritis; Sulfamethoxazole; Tri | 1990 |